Literature DB >> 15680162

An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid.

W J A Van Geel1, L E Rosengren, M M Verbeek.   

Abstract

Neurofilament light chain is a component of the axonal cytoskeleton. The concentration of the neurofilament light chain in cerebrospinal fluid may reflect axonal damage or the extent of white matter damage. In this study we describe a sensitive immunoassay for the detection of neurofilament light chain in cerebrospinal fluid using commercially available materials. The detection limit of the assay was 5 ng/l and the assay was linear up to 390 ng/l. Mean recovery was 91.5% and inter-assay and intra-assay coefficients of variation were below 18%. Strongly increased levels of neurofilament light chain were observed in patients with cerebrovascular accidents, subarachnoid hemorrhage and severe traumatic brain injury, suggesting the occurrence of axonal damage in these conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15680162     DOI: 10.1016/j.jim.2004.11.015

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  22 in total

1.  Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage.

Authors:  E R Zanier; D Refai; G J Zipfel; T Zoerle; L Longhi; T J Esparza; M L Spinner; R J Bateman; D L Brody; N Stocchetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-22       Impact factor: 10.154

2.  Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury.

Authors:  Sandra Magnoni; Thomas J Esparza; Valeria Conte; Marco Carbonara; Giorgio Carrabba; David M Holtzman; Greg J Zipfel; Nino Stocchetti; David L Brody
Journal:  Brain       Date:  2011-11-23       Impact factor: 13.501

Review 3.  Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Lucas T Vu; Robert Bowser
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  Axonal damage and outcome in subarachnoid haemorrhage.

Authors:  A Petzold; G Keir; A Kay; M Kerr; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06       Impact factor: 10.154

5.  CSF neurofilament proteins in the differential diagnosis of dementia.

Authors:  D de Jong; R W M M Jansen; Y A L Pijnenburg; W J A van Geel; G F Borm; H P H Kremer; M M Verbeek
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-21       Impact factor: 10.154

Review 6.  Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era.

Authors:  Albert M Anderson; Qing Ma; Scott L Letendre; Jennifer Iudicello
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-15       Impact factor: 5.071

7.  CSF neurofilament protein analysis in the differential diagnosis of ALS.

Authors:  Thierry S Reijn; Wilson F Abdo; Helenius J Schelhaas; Marcel M Verbeek
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

Review 8.  Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?

Authors:  Johannes Brettschneider; Axel Petzold; Sigurd Süssmuth; Hayrettin Tumani
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

9.  Plasma Neurofilament Light Chain Is Associated with Poor Functional Outcome and Mortality Rate After Spontaneous Subarachnoid Hemorrhage.

Authors:  Claus Vinter Bodker Hviid; Signe Voigt Lauridsen; Tua Gyldenholm; Niels Sunde; Tina Parkner; Anne-Mette Hvas
Journal:  Transl Stroke Res       Date:  2019-12-05       Impact factor: 6.829

10.  CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.

Authors:  Sahra Abdulle; Asa Mellgren; Bruce J Brew; Paola Cinque; Lars Hagberg; Richard W Price; Lars Rosengren; Magnus Gisslén
Journal:  J Neurol       Date:  2007-04-10       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.